Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer
Background: Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.
T Kitani, SG Ong, CK Lam, JW Rhee, JZ Zhang… - Circulation, 2019 - europepmc.org
Background Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
T Kitani, SG Ong, CK Lam, JW Rhee, JZ Zhang… - Circulation, 2019 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Molecular targeted
chemotherapies have been shown to significantly improve the outcomes of patients who …
chemotherapies have been shown to significantly improve the outcomes of patients who …
[HTML][HTML] Human Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Breast Cancer Patients
T Kitani, SG Ong, CK Lam, JW Rhee, JZ Zhang… - Circulation, 2019 - ncbi.nlm.nih.gov
Background: Molecular targeted chemotherapies have been shown to significantly improve
cancer patient outcomes, but often cause cardiovascular side effects that limit their use and …
cancer patient outcomes, but often cause cardiovascular side effects that limit their use and …
[PDF][PDF] Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
N Ma, L Tian, J Lee, ML Telli, RM Witteles, A Sharma… - Circulation, 2019 - researchgate.net
BACKGROUND: Molecular targeted chemotherapies have been shown to significantly
improve the outcomes of patients who have cancer, but they often cause cardiovascular side …
improve the outcomes of patients who have cancer, but they often cause cardiovascular side …
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
T Kitani, SG Ong, CK Lam, JW Rhee… - …, 2019 - scholarworks.bwise.kr
Background: Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
T Kitani, SG Ong, CK Lam, JW Rhee… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.
T Kitani, SG Ong, CK Lam, JW Rhee, JZ Zhang… - Circulation, 2019 - europepmc.org
Background Molecular targeted chemotherapies have been shown to significantly improve
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
the outcomes of patients who have cancer, but they often cause cardiovascular side effects …
[PDF][PDF] Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
N Ma, L Tian, J Lee, ML Telli, RM Witteles, A Sharma… - Circulation, 2019 - researchgate.net
BACKGROUND: Molecular targeted chemotherapies have been shown to significantly
improve the outcomes of patients who have cancer, but they often cause cardiovascular side …
improve the outcomes of patients who have cancer, but they often cause cardiovascular side …